BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30536069)

  • 1. Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series.
    Zeng XY; Yin YP; Xiao H; Zhang P; He J; Liu WZ; Gao JB; Shuai XM; Wang GB; Wu XL; Tao KX
    Curr Med Sci; 2018 Dec; 38(6):1054-1061. PubMed ID: 30536069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and prognostic features of hepatoid adenocarcinoma of the stomach.
    Zhang JF; Shi SS; Shao YF; Zhang HZ
    Chin Med J (Engl); 2011 May; 124(10):1470-6. PubMed ID: 21740800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emphasis on the clinical relationship between alpha-fetoprotein and hepatoid adenocarcinoma of the stomach: a retrospective study.
    Li L; Yang X; Ji W; Zhu Q; Yang X; Niu J; Li W
    BMC Gastroenterol; 2023 May; 23(1):142. PubMed ID: 37161409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological features and prognosis of intestinal hepatoid adenocarcinoma: evaluation of a pooled case series.
    Zeng X; Zhang P; Xiao H; Wu X; Liu W; He J; Gao J; Wang G; Shuai X; Tao K
    Oncotarget; 2018 Jan; 9(2):2715-2725. PubMed ID: 29416804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathologic characteristics and prognosis of gastric hepatoid adenocarcinoma].
    Zhao R; Wang X; Lan X; Li M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1035-1039. PubMed ID: 28900996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics, diagnosis and treatment of hepatoid adenocarcinoma of the stomach].
    Yang CK; Zhao WJ; Dai QB; Zhang HH; Zheng W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):245-8. PubMed ID: 17520383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologial features of gastric hepatoid adenocarcinoma.
    Lin CY; Yeh HC; Hsu CM; Lin WR; Chiu CT
    Biomed J; 2015; 38(1):65-9. PubMed ID: 25163499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach.
    Lin JX; Wang ZK; Hong QQ; Zhang P; Zhang ZZ; He L; Wang Q; Shang L; Wang LJ; Sun YF; Li ZX; Liu JJ; Ding FH; Lin ED; Fu YA; Lin SM; Xie JW; Li P; Zheng CH; Huang CM
    JAMA Netw Open; 2021 Oct; 4(10):e2128217. PubMed ID: 34609494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [AFP-producing gastric cancer and hepatoid gastric cancer].
    Wang YK; Zhang XT
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):801-807. PubMed ID: 29151285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-fetoprotein-producing gastric carcinoma presenting focal hepatoid differentiation in metastatic lymph nodes.
    Kang GH; Kim YI
    Virchows Arch; 1998 Jan; 432(1):85-7. PubMed ID: 9463592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
    Liu X; Sheng W; Wang Y
    J Surg Oncol; 2012 Sep; 106(3):299-303. PubMed ID: 22389029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level of serum AFP is an independent negative prognostic factor in gastric cancer.
    Chen Y; Qu H; Jian M; Sun G; He Q
    Int J Biol Markers; 2015 Nov; 30(4):e387-93. PubMed ID: 26349668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
    Li B; Sun L; Wang X; Deng J; Ding X; Wang X; Ke B; Zhang L; Zhang R; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):207-212. PubMed ID: 28226357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features.
    Wang Y; Sun L; Li Z; Gao J; Ge S; Zhang C; Yuan J; Wang X; Li J; Lu Z; Gong J; Lu M; Zhou J; Peng Z; Shen L; Zhang X
    Gastric Cancer; 2019 Nov; 22(6):1183-1192. PubMed ID: 30989433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoid adenocarcinoma of the stomach.
    Inagawa S; Shimazaki J; Hori M; Yoshimi F; Adachi S; Kawamoto T; Fukao K; Itabashi M
    Gastric Cancer; 2001; 4(1):43-52. PubMed ID: 11706627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of liver metastasis of gastric hepatoid adenocarcinoma].
    Jeong EH; Kim DH; Ma SH; Chung EJ; Bae SS; Park AY; Chu HJ
    Korean J Hepatol; 2009 Jun; 15(2):201-8. PubMed ID: 19581772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
    Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
    Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
    Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
    BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.